Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
Crossref DOI link: https://doi.org/10.1038/s41392-022-01164-y
Published Online: 2022-09-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, Ning
Hu, Hanguang
Yuan, Ying http://orcid.org/0000-0002-3922-9553
Text and Data Mining valid from 2022-09-05
Version of Record valid from 2022-09-05
Article History
Received: 29 June 2022
Revised: 27 July 2022
Accepted: 10 August 2022
First Online: 5 September 2022
Competing interests
: The author declares no competing interests.